- Piper upgrades Forest Labs (FRX -0.2%) to Overweight from Neutral. Price target is $67.
- Morgan Stanley cuts AbbVie (ABBV -3.3%) to Equalweight from Overweight.
- Leerink downgrades Solta Medical (SLTM) to Market Perform from Outperform.
- Stifel cuts Puma Biotechnology (PBYI -0.8%) to Hold from Buy.
- Chardan starts Rockwell Medical (RMTI +3.2%) at Buy. Price target is $22.
- JMP starts Chelsea Therapeutics (CHTP +5.5%) at Market Outperform. Price target is $8.
Healthcare upgrades, downgrades, and initiations for Thursday
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at MarketWatch.com (Jul 1, 2014)
at CNBC.com (Jul 1, 2014)
at CNBC.com (Jun 24, 2014)
at CNBC.com (Jun 17, 2014)
at CNBC.com (May 27, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs